192 related articles for article (PubMed ID: 12920263)
1. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.
Marshall JW; Cummings RM; Bowes LJ; Ridley RM; Green AR
Stroke; 2003 Sep; 34(9):2228-33. PubMed ID: 12920263
[TBL] [Abstract][Full Text] [Related]
2. NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species.
Marshall JW; Duffin KJ; Green AR; Ridley RM
Stroke; 2001 Jan; 32(1):190-8. PubMed ID: 11136936
[TBL] [Abstract][Full Text] [Related]
3. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures.
Marshall JW; Green AR; Ridley RM
Brain Res; 2003 May; 972(1-2):119-26. PubMed ID: 12711084
[TBL] [Abstract][Full Text] [Related]
5. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
[TBL] [Abstract][Full Text] [Related]
8. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
Maples KR; Green AR; Floyd RA
CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
[TBL] [Abstract][Full Text] [Related]
9. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke.
Lees KR; Sharma AK; Barer D; Ford GA; Kostulas V; Cheng YF; Odergren T
Stroke; 2001 Mar; 32(3):675-80. PubMed ID: 11239186
[TBL] [Abstract][Full Text] [Related]
11. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
[TBL] [Abstract][Full Text] [Related]
12. NXY-059: review of neuroprotective potential for acute stroke.
Fong JJ; Rhoney DH
Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
[TBL] [Abstract][Full Text] [Related]
13. NXY-059: a hopeful sign in the treatment of stroke.
Hess DC
Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
[No Abstract] [Full Text] [Related]
14. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.
Lapchak PA; Song D; Wei J; Zivin JA
Exp Neurol; 2004 Aug; 188(2):279-85. PubMed ID: 15246827
[TBL] [Abstract][Full Text] [Related]
15. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.
Green AR; Lanbeck-Vallén K; Ashwood T; Lundquist S; Lindström Böö E; Jonasson H; Campbell M
Brain Res; 2006 Feb; 1072(1):224-6. PubMed ID: 16448628
[TBL] [Abstract][Full Text] [Related]
16. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.
Bath PM; Gray LJ; Bath AJ; Buchan A; Miyata T; Green AR;
Br J Pharmacol; 2009 Aug; 157(7):1157-71. PubMed ID: 19422398
[TBL] [Abstract][Full Text] [Related]
17. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
Green AR; Ashwood T
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.
Kuroda S; Tsuchidate R; Smith ML; Maples KR; Siesjö BK
J Cereb Blood Flow Metab; 1999 Jul; 19(7):778-87. PubMed ID: 10413033
[TBL] [Abstract][Full Text] [Related]
19. Serial MRI, functional recovery, and long-term infarct maturation in a non-human primate model of stroke.
Marshall JW; Ridley RM; Baker HF; Hall LD; Carpenter TA; Wood NI
Brain Res Bull; 2003 Oct; 61(6):577-85. PubMed ID: 14519454
[TBL] [Abstract][Full Text] [Related]
20. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
Green AR; Ashwood T; Odergren T; Jackson DM
Pharmacol Ther; 2003 Dec; 100(3):195-214. PubMed ID: 14652110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
